Homeland Security Today: A $10 million contract to develop novel medicines and diagnostics that can be used to thwart bioterrorism threats or an infectious disease epidemic has been awarded to SRI Biosciences by the SPAWAR Systems Center as part of the Defense Advanced Research Projects Agency’s (DARPA) Folded Non-Natural Polymers with Biological Functions program, known as Fold F(x).
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now